Clinical Data's Q1 Revenues Rise 52 Percent; PGx Division up 7 Percent

Aug 09, 2010

NEW YORK (GenomeWeb News) – Clinical Data today reported that its first-quarter 2011 revenues jumped 52 percent, due in large part to a $2 million milestone payment received from Santen Pharmaceuticals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

This Week in PLOS

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

Things Not Found

With a new collection, PLOS highlights negative results it has published.

Is the Sequencer Half Full or Half Empty?

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

Packs a Punch

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds onto important genes.

Main menu